NMIMC
ICPT

Northwestern Mutual Investment Management Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,880
Closed -$281K – 1018
2015
Q4 		$281K Hold
1,880
– – 0.01% 667
2015
Q3 		$312K Hold
1,880
– – 0.01% 658
2015
Q2 		$454K Buy
1,880
+410
+28% +$109K 0.01% 618
2015
Q1 		$415K Buy
+1,470
New +$318K 0.01% 630

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northwestern Mutual Investment Management Company's ICPT Position: Q1 2016 in Review

Northwestern Mutual Investment Management Company sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2016, closing a stake of 1,880 shares — an estimated $281K sold.

Northwestern Mutual Investment Management Company first reported a position in ICPT in Q1 2015 and held it in 4 quarters. The position peaked at $454K in Q2 2015. 160 funds tracked by Wall St. Rank hold ICPT as of Q1 2016.

  • Northwestern Mutual Investment Management Company reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Northwestern Mutual Investment Management Company sold 1,880 Intercept Pharmaceuticals, Inc. shares in Q1 2016, an estimated $281K.
  • Northwestern Mutual Investment Management Company first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
  • Northwestern Mutual Investment Management Company's Intercept Pharmaceuticals, Inc. position peaked at $454K in Q2 2015.
  • 160 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2016.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q1 2016, filed 16 May 2016.